B
The startup develops a cancer monitoring system that combines a beta particle detector with a surgical aspirator to enhance precision during oncology surgeries. This technology enables surgeons to accurately differentiate between healthy and tumorous tissues, ensuring clear margins and improving patient outcomes.
Updated 20 months ago
Funding
$970K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
A
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops a cancer monitoring system that combines a beta particle detector with a surgical aspirator to enhance precision during oncology surgeries. This technology enables surgeons to accurately differentiate between healthy and tumorous tissues, ensuring clear margins and improving patient outcomes.